UPDATED May 06, 2024
Well rounded companies, with acceptable leverage, projected to deliver an ROE north of 20% in three years.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
2330 | NT$798.00 | 1.0% | 56.5% | NT$20.4t | NT$912.98 | PE24.1x | E16.1% | 1.8% | Semiconductors | ||
AZN | UK£120.50 | 0.2% | 1.1% | UK£186.8b | UK£131.66 | PE37.1x | E16.5% | 2.0% | Pharmaceuticals & Biotech | ||
QCOM | US$181.85 | 7.5% | 67.9% | US$202.9b | US$185.20 | PE24x | E8.7% | 1.8% | Semiconductors | ||
NOVN | CHF88.10 | -0.9% | -6.0% | CHF179.8b | CHF98.16 | PE21.8x | E10.0% | 3.7% | Pharmaceuticals & Biotech | ||
ROG | CHF218.50 | -1.2% | -23.1% | CHF176.2b | CHF279.39 | PE15.2x | E8.6% | 4.4% | Pharmaceuticals & Biotech | ||
SAF | €206.40 | 0.7% | 50.2% | €85.4b | €213.68 | PE24.8x | E7.2% | 1.1% | Capital Goods | ||
ZURN | CHF446.00 | 0.4% | 3.3% | CHF64.2b | CHF461.86 | PE16.3x | E8.9% | 5.7% | Insurance | ||
SLB | US$47.96 | -2.5% | 2.9% | US$68.6b | US$66.67 | PE15.8x | E15.3% | 2.3% | Energy | ||
300760 | CN¥313.16 | 3.7% | 4.0% | CN¥378.7b | CN¥395.04 | PE31.1x | E15.1% | 1.9% | Healthcare | ||
2454 | NT$1,035.00 | 2.0% | 53.3% | NT$1.6t | NT$1,209.58 | PE21.4x | E13.2% | 5.9% | Semiconductors | ||
BBRI | Rp4,790.00 | 0.4% | -6.1% | Rp716.3t | Rp6,258.00 | PB2.5x | E9.6% | 6.7% | Banks | ||
BMRI | Rp6,275.00 | -9.4% | 22.4% | Rp574.0t | Rp7,525.29 | PB2.4x | E9.6% | 5.6% | Banks | ||
HAL | ₹3,816.40 | -5.0% | 158.0% | ₹2.6t | ₹3,091.36 | PE41.5x | E10.0% | 0.8% | Capital Goods | ||
EVO | kr1,204.00 | -1.7% | -6.4% | kr254.1b | kr1,489.06 | PE20x | E12.4% | 2.6% | Consumer Services | ||
300274 | CN¥105.68 | -0.6% | -2.0% | CN¥155.2b | CN¥130.74 | PE15.5x | E11.3% | 0.9% | Capital Goods | ||
KCHOL | ₺234.40 | 4.2% | 190.8% | ₺594.4b | ₺215.07 | PE8.2x | E26.5% | 3.4% | Capital Goods | ||
SOON | CHF262.80 | 1.7% | -8.3% | CHF15.7b | CHF270.88 | PE26.1x | E10.7% | 1.8% | Healthcare | ||
ALL | AU$39.45 | -0.8% | 4.4% | AU$25.0b | AU$47.49 | PE17.2x | E5.1% | 1.7% | Consumer Services | ||
300122 | CN¥37.03 | 3.7% | -28.1% | CN¥88.6b | CN¥62.47 | PE11.8x | E22.8% | 2.2% | Pharmaceuticals & Biotech | ||
600845 | CN¥41.91 | 3.7% | -6.5% | CN¥84.9b | CN¥49.57 | PE38.1x | E21.4% | 2.4% | Software | ||
3231 | NT$114.00 | 0.4% | 128.0% | NT$327.3b | NT$152.34 | PE28.5x | E31.2% | 2.3% | Tech | ||
DOX | US$84.95 | 0.09% | -5.9% | US$9.9b | US$104.90 | PE17.7x | E15.8% | 2.3% | Software | ||
300896 | CN¥222.95 | 2.4% | -39.2% | CN¥67.1b | CN¥315.86 | PE34x | E25.2% | 1.5% | Pharmaceuticals & Biotech | ||
2648 | CN¥19.80 | 3.6% | 39.1% | CN¥66.6b | CN¥21.45 | PE13x | E19.5% | 2.0% | Materials |